Dr. Talal Almas has authored more than 145+ PubMed-indexed publications with over 1200 citations, placing his scholarly impact within the top 5% globally by H-index in his peer range. His research focuses on cardiovascular outcomes in heart failure therapeutics, device innovation for HFpEF, cardiovascular prevention, and cardiogenic shock/critical care. His work has been presented at major national conferences, including numerous posters and presentations at ACC, AHA, TCT, JSCAI. His long-term goal is to lead clinical trials and advance therapies in heart failure, cardiogenic shock and cardiovascular critical care.